Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Folkman, J. Tumor Angiogenesis: Therapeutic Implications. New Eng. J. Med. 285, 1182–1186(1971).

  2. 2

    Tuder, R.M., Flook, R.E. & Voelkel, N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. J. Clin. Invest. 95, 1798–1807 (1995).

  3. 3

    Banai, S. et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183–2189(1994).

  4. 4

    Bauters, C., et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21, 314–325 (1995).

  5. 5

    Takeshita, S. et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90, 228–234 (1994).

  6. 6

    Henry, T.D. et al. Results of intracoronary recombinant human vascular endothelial growth factor administration trial. J. Am. Coll. Card. 31, 65A (1998).

  7. 7

    Klagsbrun, M. The fibroblast growth factor family: Structural and biological properties. Prog. Growth Factor Res. 1, 207–235 (1989).

  8. 8

    Unger, E.F. et al. Basic fibroblast growth factor enhances myocardial collateral flow in canine model. Am. J. Physiol. 266, H1588–1595 (1994).

  9. 9

    Lazarous, D.F. et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145–153(1995).

  10. 10

    Lazarous, D.F. et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074–1082 (1996).

  11. 11

    Mazue, G. et al. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol. Pathol. 21, 490–501 (1993).

  12. 12

    Schumacher, B., Pecher, P., Von Specht, B.U. & Induction of neoan-giogenesis in ischemic myocardium by human growth factors. Circulation 97, 645–650(1998).

  13. 13

    Suri, C., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171–1180 (1996).

  14. 14

    Giordano, F.J. et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2, 534–539 (1996).

  15. 15

    Muhlhauser, J. et al. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient recombinant adenovirus vectors. Gene Ther. 3, 145–153(1996).

  16. 16

    Baumgartner, I. et al. Constitutive expression of phVEGFl 65 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114–1123 (1998).

  17. 17

    Campbell, A.I.M., Monge, J.C., Latter, M.A., Kuliszewski, M.A. & Stewart, D.J. Direct DNA injection of vascular endothelial growth factor induces angiogenesis in non-ischemic myocardium. J. Am. Coll. Card. 31, 25A (1998).

  18. 18

    Isner, J.M. et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348, 370–374 (1996).

Download references

Author information

Correspondence to Joon S. Lee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, J., Feldman, A. Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies. Nat Med 4, 739–742 (1998) doi:10.1038/nm0698-739

Download citation

Further reading